Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The evolutionary history of 2,658 cancers.

Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, Mitchell TJ, Rubanova Y, Anur P, Yu K, Tarabichi M, Deshwar A, Wintersinger J, Kleinheinz K, Vázquez-García I, Haase K, Jerman L, Sengupta S, Macintyre G, Malikic S, Donmez N, Livitz DG, Cmero M, Demeulemeester J, Schumacher S, Fan Y, Yao X, Lee J, Schlesner M, Boutros PC, Bowtell DD, Zhu H, Getz G, Imielinski M, Beroukhim R, Sahinalp SC, Ji Y, Peifer M, Markowetz F, Mustonen V, Yuan K, Wang W, Morris QD; PCAWG Evolution & Heterogeneity Working Group, Spellman PT, Wedge DC, Van Loo P; PCAWG Consortium.

Nature. 2020 Feb;578(7793):122-128. doi: 10.1038/s41586-019-1907-7. Epub 2020 Feb 6.

PMID:
32025013
2.

Inferring structural variant cancer cell fraction.

Cmero M, Yuan K, Ong CS, Schröder J; PCAWG Evolution and Heterogeneity Working Group, Corcoran NM, Papenfuss T, Hovens CM, Markowetz F, Macintyre G; PCAWG Consortium.

Nat Commun. 2020 Feb 5;11(1):730. doi: 10.1038/s41467-020-14351-8.

3.

Using equivalence class counts for fast and accurate testing of differential transcript usage.

Cmero M, Davidson NM, Oshlack A.

Version 2. F1000Res. 2019 Mar 7 [revised 2019 Jan 1];8:265. doi: 10.12688/f1000research.18276.2. eCollection 2019.

4.

Comparing nodal versus bony metastatic spread using tumour phylogenies.

Mangiola S, Hong MK, Cmero M, Kurganovs N, Ryan A, Costello AJ, Corcoran NM, Macintyre G, Hovens CM.

Sci Rep. 2016 Sep 22;6:33918. doi: 10.1038/srep33918.

5.

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression.

Stuchbery R, Macintyre G, Cmero M, Harewood LM, Peters JS, Costello AJ, Hovens CM, Corcoran NM.

Oncotarget. 2016 May 24;7(21):31384-92. doi: 10.18632/oncotarget.8915.

6.

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.

Sapre N, Macintyre G, Clarkson M, Naeem H, Cmero M, Kowalczyk A, Anderson PD, Costello AJ, Corcoran NM, Hovens CM.

Br J Cancer. 2016 Feb 16;114(4):454-62. doi: 10.1038/bjc.2015.472. Epub 2016 Jan 26.

7.

Drosha controls dendritic cell development by cleaving messenger RNAs encoding inhibitors of myelopoiesis.

Johanson TM, Keown AA, Cmero M, Yeo JH, Kumar A, Lew AM, Zhan Y, Chong MM.

Nat Immunol. 2015 Nov;16(11):1134-41. doi: 10.1038/ni.3293. Epub 2015 Oct 5.

PMID:
26437240
8.

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.

Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, Phal PM, Kurganovs N, Chin X, Kerger M, Warren AY, Neal D, Gnanapragasam V, Rosenfeld N, Pedersen JS, Ryan A, Haviv I, Costello AJ, Corcoran NM, Hovens CM.

Nat Commun. 2015 Apr 1;6:6605. doi: 10.1038/ncomms7605.

9.

A microRNA expression atlas of mouse dendritic cell development.

Johanson TM, Cmero M, Wettenhall J, Lew AM, Zhan Y, Chong MM.

Immunol Cell Biol. 2015 May-Jun;93(5):480-5. doi: 10.1038/icb.2014.109. Epub 2014 Dec 23.

PMID:
25533289
10.

Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads.

Schröder J, Hsu A, Boyle SE, Macintyre G, Cmero M, Tothill RW, Johnstone RW, Shackleton M, Papenfuss AT.

Bioinformatics. 2014 Apr 15;30(8):1064-1072. Epub 2014 Jan 2.

Supplemental Content

Support Center